Novo-Nordisk A/S ADS (NVO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

NOVO ALLE DK 2880 BAGSVAERD DENMARK, DENMARK

Novo Nordisk A/S is a Denmark-based company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company reports two business segments: Diabetes and Biopharmaceuticals. Diabetes division offers a range of diabetes products, including modern insulins, such as NovoRapid, NovoMix and Levemir; new-generation insulins, such as Degludes and DegludecPlus; as well as the FlexTouch insulin pen, among others. Biopharmaceuticals division provides treatments for people with haemophilia, growth hormone deficiency and for women experiencing symptoms of menopause. As of December 31, 2011, the Company marketed its products in more than 190 countries. It reports five geographical regions, namely North America, Europe, Region China, Japan and Korea, as well as International Operations. The Company wholly owns over 70 subsidiaries, such as Novo Nordisk Pharma GmbH, Novo Nordisk Canada Inc., Novo Nordisk Region Japan & Korea A/S, among others.

Data based on most recent fiscal year report
Market Cap28.501 Billion Shares Outstanding580 Million Avg Volume3.015 Million
1-Yr BETA vs S&P TR0.413 Current Ratio1.91 Quick Ratio1.45
View SEC Filings from NVO instead.
Q3 2019 All Institutions Hedge Funds 1
To trade NVO now:
Filers who had this stock in their top 10: 8 1 (0.1%)
13F Filers holding this stock: 533 46 (4.81%)
Aggregate 13F shares on 09/30/2019: 169.17 Million 49.474 Million
Aggregate 13F shares on 06/30/2019: 174.003 Million 47.009 Million
Percent change: -2.78% 5.24%
Funds creating new positions: 52 6
Funds Adding to an existing position: 170 15
Funds closing out their position: 42 5
Funds reducing their position: 201 16
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding NVO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments